PEBIOR Trademark

Trademark Overview

On Thursday, June 20, 2013, a trademark application was filed for PEBIOR with the United States Patent and Trademark Office. The USPTO has given the PEBIOR trademark a serial number of 85965588. The federal status of this trademark filing is ABANDONED - EXPRESS AFTER PUB as of Friday, August 22, 2014. This trademark is owned by Celgene Corporation. The PEBIOR trademark is filed in the Pharmaceutical Products category with the following description:

pharmaceutical preparations that modulate the immune system; pharmaceutical preparations, namely, cytokine inhibitory drugs; pharmaceutical preparations for the treatment of oncology, inflammation, dermatology and ophthalmology diseases and illnesses
pebior

General Information

Serial Number85965588
Word MarkPEBIOR
Filing DateThursday, June 20, 2013
Status605 - ABANDONED - EXPRESS AFTER PUB
Status DateFriday, August 22, 2014
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 29, 2014

Trademark Statements

Goods and Servicespharmaceutical preparations that modulate the immune system; pharmaceutical preparations, namely, cytokine inhibitory drugs; pharmaceutical preparations for the treatment of oncology, inflammation, dermatology and ophthalmology diseases and illnesses

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code8 - Abandoned
Class Status DateFriday, August 22, 2014
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameCelgene Corporation
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSummit, NJ 07901
Party NameCelgene Corporation
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSummit, NJ 07901

Trademark Events

Event DateEvent Description
Friday, August 22, 2014ABANDONMENT NOTICE MAILED - AFTER PUBLICATION
Friday, August 22, 2014ABANDONMENT - AFTER PUBLICATION
Wednesday, August 20, 2014TEAS EXPRESS ABANDONMENT RECEIVED
Thursday, May 22, 2014EXTENSION OF TIME TO OPPOSE RECEIVED
Tuesday, April 29, 2014OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 29, 2014PUBLISHED FOR OPPOSITION
Wednesday, April 9, 2014NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, March 21, 2014LAW OFFICE PUBLICATION REVIEW COMPLETED
Thursday, March 20, 2014APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, March 20, 2014TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, March 20, 2014CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, March 17, 2014ASSIGNED TO LIE
Friday, February 28, 2014TEAS VOLUNTARY AMENDMENT RECEIVED
Thursday, February 27, 2014EXAMINER'S AMENDMENT ENTERED
Thursday, February 27, 2014NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Thursday, February 27, 2014EXAMINERS AMENDMENT E-MAILED
Thursday, February 27, 2014EXAMINERS AMENDMENT -WRITTEN
Wednesday, February 26, 2014TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, February 25, 2014CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, February 25, 2014TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, October 2, 2013NOTIFICATION OF PRIORITY ACTION E-MAILED
Wednesday, October 2, 2013PRIORITY ACTION E-MAILED
Wednesday, October 2, 2013PRIORITY ACTION WRITTEN
Thursday, September 26, 2013ASSIGNED TO EXAMINER
Friday, July 5, 2013NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Monday, June 24, 2013NEW APPLICATION ENTERED IN TRAM

Related Keywords

pebior pharmaceutical preparations inflammation oncology dermatology ophthalmology illnesses diseases treatment inhibitory